Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
South Korea Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
South Korea vaccine market size reached USD 1,185.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,648.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.74% duri...
July 2026
118 pages
Combination Vaccines Market - 2026-2033
US$ 3,400.00
Combination Vaccines Market reached USD 6.03 Billion in 2025 and is expected to reach USD 12.9 Billion by 2033, growing with a CAGR of 10.60% during the forecast period 2026-2033. The Combination Vacc...
June 2026
46 pages
Vaccine Adjuvants Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Diseases, Application, and Region, 2026-2034
US$ 2,999.00
The global vaccine adjuvants market size reached USD 1,223.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,987.6 Million by 2034, exhibiting a growth rate (CAGR) of 1...
June 2026
136 pages
Mexico Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine),Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
Mexico vaccine market size reached USD 1.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.45% during 2026-2034....
June 2026
121 pages
Human DNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human DNA Vaccine Market is projected for substantial growth, expanding from USD 371.02 Million in 2025 to USD 581.28 Million by 2031, demonstrating a CAGR of 7.77%. These advanced immunizi...
May 2026
189 pages
Bacterial Vaccines Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, Geriatric Vaccines), By Distribution Channel (Government Agencies and Programs, Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Others) , By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bacterial Vaccines Market is projected to expand from USD 7.19 billion in 2025 to USD 10.94 billion by 2031, achieving a 7.25% CAGR. Bacterial vaccines are biological agents designed to sti...
May 2026
185 pages
Nasal Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines, Others), By Application (Influenza, COVID-19, Others (such as Cholera, Typhoid, etc.)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Nasal Vaccines Market is projected to expand significantly, growing from USD 434.21 Million in 2025 to USD 623.29 Million by 2031, at a Compound Annual Growth Rate of 6.21%. These vaccines...
May 2026
180 pages
Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Conjugate Vaccines, Polysaccharide Vaccines), By Indication (Bronchitis, Meningitis, Pneumonia, Sepsis), By Product (Pneumovax23, Prevnar 13, Synflorix), By Distribution (Government Authorities, Non-Governmental Organizations), By Region & Competition, 2021-2031F
US$ 4,500.00
The global pneumococcal vaccine market is projected to expand significantly, from USD 9.71 billion in 2025 to USD 13.98 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.26%. Th...
May 2026
185 pages
Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Adjuvant Emulsions, Pathogen Components, Saponin-Based Adjuvants, Particulate Adjuvants, Other Adjuvants), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Application (Research Applications, Commercial Applications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Vaccine Adjuvants Market is projected to expand significantly, rising from USD 0.83 Billion in 2025 to USD 1.22 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.63%. Vaccine ad...
May 2026
180 pages
BCG Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Immune BCG, Therapy BCG), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global BCG Vaccines Market is projected to expand robustly, growing from USD 149.71 Million in 2025 to USD 212.01 Million by 2031, at a compound annual growth rate of 5.97%. The Bacillus Calmette-...
May 2026
180 pages
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, Intranasal Vaccines), By Type of Brand (Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global H1N1 Vaccines Market is projected to expand from USD 10.13 billion in 2025 to USD 13.07 billion by 2031, demonstrating a compound annual growth rate of 4.34%. These vaccines, typically foun...
May 2026
185 pages
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit and Killed Oral O1 & O139), By Product (Vaxchora, Dukoral, Shanchol, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global cholera vaccines market is projected to expand significantly, growing from USD 97.32 Million in 2025 to USD 166.11 Million by 2031 at a 9.32% CAGR. These biological preparations, primarily...
May 2026
180 pages
Measles, Mumps, Rubella Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Monovalent, Trivalent (combined MMR), Tetravalent), By Targeted Population (Infants and children (9 months to 12), Adults), By Distribution Channel (Hospitals and Healthcare Institutions, Vaccine Centers and Public Health Clinics, Pediatric and Private Healthcare Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Measles, Mumps, Rubella (MMR) Vaccine Market is projected to expand significantly, rising from USD 2.19 Billion in 2025 to USD 3.65 Billion by 2031, demonstrating an 8.89% Compound Annual G...
May 2026
189 pages
Global Consumption Type Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Consumption Type Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The driving factors of Con...
May 2026
110 pages
Global Seasonal Vaccines Market Growth 2026-2032
US$ 3,660.00
The global Seasonal Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The driving factors for seasonal...
May 2026
110 pages
Ebola Virus Vaccine Market - 2026-2033
US$ 3,400.00
Ebola Virus Vaccine Marketis is growing with a CAGR of 6.40% during the forecast period 2026-2035. The Ebola Virus Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
May 2026
45 pages
Global Microarray Patch Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Microarray Patch Vaccine market size is predicted to grow from US$ 21.67 million in 2025 to US$ 37.26 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032. A microarr...
May 2026
113 pages
Vaccine Market Forecasts to 2034 – Global Analysis By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines, Viral Vector Vaccines, DNA Vaccines, and Combination Vaccines), Valency Type, Disease Indication, Route of Administration, Age Group, Manufacturing Model, Storage & Logistics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Vaccine Market is accounted for $91.4 billion in 2026 and is expected to reach $155.9 billion by 2034 growing at a CAGR of 6.9% during the forecast period. Vac...
May 2026
200 pages
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Vaginal and Vulvar Cancers, Anal Cancer, Oropharyngeal (Head and Neck) Cancers, Genital Warts), By Distribution Channel (Hospitals and Retail Pharmacies, Government Suppliers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for Human Papillomavirus vaccines is anticipated to expand from USD 8.47 Billion in 2025 to USD 14.12 Billion by 2031, experiencing a compound annual growth rate of 8.89%. HPV vaccin...
May 2026
180 pages
Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type (Smartphones, Tablets, Others), By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Digital Vaccine Market is anticipated to expand from USD 2.21 Billion in 2025 to USD 3.55 Billion by 2031, reflecting an 8.22% CAGR. A digital vaccine is a software-driven intervention acce...
May 2026
180 pages
Coronavirus Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Coronavirus Vaccine Market is anticipated to expand from USD 51.23 billion in 2025 to USD 62.97 billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.5%. These biological pr...
May 2026
185 pages
Africa Vaccine Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 3,840.00
Africa Vaccine Market was valued at USD $250 million in 2026 and is projected to reach USD $690 million by 2035, registering a CAGR of 12.0% across the forecast period. The Africa Vaccine Market conti...
May 2026
445 pages
Global DTP Vaccine Market Growth 2026-2032
US$ 3,660.00
The global DTP Vaccine market size is predicted to grow from US$ 5747 million in 2025 to US$ 6440 million in 2032; it is expected to grow at a CAGR of 1.6% from 2026 to 2032. The DTP vaccine is a comb...
April 2026
112 pages
Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated, Live Attenuated), By Indication, By Age Group (Pediatric, Adults), By Route Of Administration (Injection, Nasal Spray), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global influenza vaccine market size was estimated at USD 8,924.13 million in 2025 and is projected to reach USD 14,797.35 million by 2033, growing at a CAGR of 6.51% from 2026 to 2033. The influe...
April 2026
150 pages
Vaccine Adjuvants Market - 2026-2033
US$ 3,400.00
Vaccine Adjuvants Marketis is growing with a CAGR of 6.90% during the forecast period 2026-2035. The Vaccine Adjuvants Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
April 2026
43 pages
